Announcements Trials
Browse Landscape

Phase

Phase 1/2 2Phase 2 1

Status

Completed 3Terminated 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Liver Metastases 2Liver Neoplasms 1

Interventions

Cyclophosphamide 641Bevacizumab 552Paclitaxel 534Carboplatin 533Cisplatin 480pembrolizumab 456Gemcitabine 422Docetaxel 415Rituximab 386Radiotherapy 373Dexamethasone 351Doxorubicin 330Nivolumab 308Fluorouracil 286Capecitabine 260Etoposide 245Prednisone 244Oxaliplatin 242Erlotinib Hydrochloride 242Cytarabine 233Lenalidomide 232Trastuzumab 226Pemetrexed 220Vincristine 212fludarabine phosphate 208Leucovorin 208Cetuximab 208Filgrastim 204Bortezomib 193Methotrexate 183

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Completed × Has results × Electrochemotherapy × Clear all
NCT02291133 2021-07-23

ECT-HCC

University Medical Centre Ljubljana

Phase 1/2 Completed
25 enrolled 6 charts
Gastrointestinal

Liver Neoplasms

NCT02352259 2021-03-24

Treatment of Liver Metastases With Electrochemotherapy (ECTJ) Phase II

Institute of Oncology Ljubljana

Phase 2 Completed
23 enrolled 6 charts

Liver Metastases

NCT01264952 2020-11-24

ECTJ

Institute of Oncology Ljubljana

Phase 1/2 Completed
16 enrolled 9 charts

Liver Metastases

Data powered by HemOnc (CC BY 4.0) Colophon âš¡